Danaher Co. (NYSE:DHR) Stock Holdings Reduced by Evercore Wealth Management LLC

Evercore Wealth Management LLC cut its position in shares of Danaher Co. (NYSE:DHR) by 0.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,963 shares of the conglomerate’s stock after selling 65 shares during the period. Evercore Wealth Management LLC’s holdings in Danaher were worth $5,730,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in DHR. Heck Capital Advisors LLC acquired a new position in shares of Danaher during the 4th quarter worth $27,000. Decker Retirement Planning Inc. acquired a new position in shares of Danaher during the 4th quarter valued at about $31,000. Golden State Wealth Management LLC bought a new position in shares of Danaher in the 4th quarter valued at approximately $31,000. Strategic Financial Concepts LLC acquired a new stake in Danaher in the 4th quarter worth approximately $31,000. Finally, Pineridge Advisors LLC boosted its position in Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after purchasing an additional 57 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on DHR. Stifel Nicolaus raised shares of Danaher from a “hold” rating to a “buy” rating and set a $260.00 price target on the stock in a research report on Friday, March 14th. Raymond James reissued a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. Citigroup restated a “buy” rating on shares of Danaher in a report on Monday, April 7th. JPMorgan Chase & Co. dropped their price objective on Danaher from $280.00 to $260.00 and set an “overweight” rating on the stock in a research note on Tuesday. Finally, The Goldman Sachs Group upgraded Danaher from a “neutral” rating to a “buy” rating and set a $260.00 target price for the company in a research note on Friday, March 21st. Four research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. According to data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and a consensus price target of $271.55.

Danaher Stock Up 3.8 %

Shares of DHR opened at $192.06 on Wednesday. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The company has a 50-day moving average price of $201.41 and a two-hundred day moving average price of $225.77. The stock has a market cap of $137.27 billion, a price-to-earnings ratio of 36.38, a P/E/G ratio of 2.66 and a beta of 0.86. Danaher Co. has a 12 month low of $171.00 and a 12 month high of $281.70.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping the consensus estimate of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The business had revenue of $5.74 billion during the quarter, compared to the consensus estimate of $5.58 billion. Equities analysts predict that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.67%. The ex-dividend date is Friday, March 28th. This is an increase from Danaher’s previous quarterly dividend of $0.27. Danaher’s payout ratio is currently 24.24%.

Insider Buying and Selling

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 11.10% of the stock is currently owned by corporate insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.